At the start of the year, infectious disease experts across California were, in their own words, stumbling around in a blind frenzy.

When President Barack Obama abandoned a public insurance option to win moderate support for the Affordable Care Act in 2009, progressives were enraged. A decade later, Joe Biden campaigned on making the public option a reality, but so far, he's done little to get Congress to enact one.

As the covid crisis wanes and life approaches normal across the U.S., health industry leaders and many patient advocates are pushing Congress and the Biden administration to preserve the pandemic-fueled expansion of telehealth that has transformed how millions of Americans see the doctor. The broad effort reaches across the nation’s diverse health care system, bringing ...

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment. Health care experts expect broad coverage of the drug, which was approved Monday. But what that means for patients will vary widely depending on their insurance plan. ...

Key Findings * The latest KFF Health Tracking Poll finds majorities of the public saying many current health care proposals being discussed by lawmakers are important priorities for Congress to focus on in the coming months, and few (less than one five) saying each of the health priorities “should not be done.” While majorities of ...

Medicare beneficiaries face wide variation in spending for specialty drugs across Part D plans, according to a new analysis. A report from GoodRx finds coverage variations between plans can lead to high out-of-pocket costs for medications, based on the top specialty medications covered under an Aetna Part D plan with more than 445,000 members. For example, the ...